Gadi Riesenfeld
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Gadi Riesenfeld was the founder of Otic Pharma Ltd., founded in 2008, and served as Chairman from 2011 to 2012.
Dr. Riesenfeld is currently Chairman & Chief Executive Officer at Timestamp Ltd. since 2017.
Former jobs include President & Managing Director at Kamapharm Ltd. from 1990 to 1991, Independent Director at NurExone Biologic, Inc. from 2023 to 2026, President & Managing Director at Galisar Ltd. from 1986 to 1988, President & Chief Operating Officer at W World Corp.
from 1992 to 2005, and President at W World Corp.
from 1992 to 2006.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.04.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Timestamp Ltd. | Vorstandsvorsitzender | 01.01.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Direktor/Vorstandsmitglied | 30.01.2026 |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Gründer | 01.01.2012 |
| W WORL | Präsident | 01.01.2006 |
| W WORL | Präsident | 01.11.2005 |
Kamapharm Ltd. | Vorstandsvorsitzender | 01.05.1991 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
W World Corp.
W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
Kamapharm Ltd. | |
Galisar Ltd. | |
Timestamp Ltd. | |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen